KLOW

Product Overview

BPC-157, GHK-Cu, TB-500 and KPV in one formulation. Recent KPV research examines lipid and inflammatory signaling in cell and animal models. This evidence is specific to the component, not the KLOW blend.

KLOW is listed in the EULIX Research catalog as a 80 mg research blend.

The listed formulation combines BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg. These quantities describe the nominal presentation; measured results belong to the individual sample report.

Review the product identity, presentation and batch documentation together when consulting analytical documentation.

Product Specifications

Compound

KLOW

Presentation

80 mg

Composition

BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg

Form

Lyophilized material

Storage

Refer to label and batch documentation

Intended Purpose

Research and analytical use only

Brand

EULIX Research

Quality & Testing

Available analytical documentation identifies a specific sample. Review the published report for:

• Compound identification
• Batch or lot reference
• Analytical testing results
• Laboratory and report date